Effective treatment for T1D was concretely established in the cohort of the Diabetes Control and Complications Trial (DCCT; 1–3), which evidenced the necessity of intensive insulin therapy for the prevention of chronic complications of the disease. The gene discussed is INS; the disease is diabetes mellitus.